CeriBell, Inc (CBLL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CeriBell, Inc (CBLL) has a cash flow conversion efficiency ratio of -0.069x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-10.77 Million) by net assets ($155.34 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
CeriBell, Inc - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how CeriBell, Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read CeriBell, Inc debt and liabilities for a breakdown of total debt and financial obligations.
CeriBell, Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CeriBell, Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu Jinji Industrial Co Ltd
SHE:300798
|
-0.031x |
|
Salim Ivomas Pratama Tbk
JK:SIMP
|
0.048x |
|
Fidus Investment Corp
NASDAQ:FDUS
|
0.008x |
|
Basilea Pharmaceutica AG
SW:BSLN
|
0.224x |
|
Shenzhen Refond Optoelectronics Co Ltd
SHE:300241
|
0.014x |
|
Zhejiang Fuchunjiang Environmental Thermoelectric Co Ltd
SHE:002479
|
0.032x |
|
Zhuhai Port Co Ltd
SHE:000507
|
0.045x |
|
Kossan Rubber Industries Bhd
KLSE:7153
|
0.021x |
Annual Cash Flow Conversion Efficiency for CeriBell, Inc (2022–2025)
The table below shows the annual cash flow conversion efficiency of CeriBell, Inc from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of CeriBell, Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $155.34 Million | $-40.81 Million | -0.263x | -43.31% |
| 2024-12-31 | $191.16 Million | $-35.04 Million | -0.183x | -170.57% |
| 2023-12-31 | $-112.25 Million | $-29.16 Million | 0.260x | -29.87% |
| 2022-12-31 | $-86.40 Million | $-32.00 Million | 0.370x | -- |
About CeriBell, Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly t… Read more